Enzyme inhibitors

The present invention provides compounds of Formula (I) or (Ia): compositions comprising such compounds; the use of such compounds in therapy; and methods of treating patients using such compounds; wherein A, B, n, R2, R3, R4, R5 and R6 are as defined herein. 本发明提供式(I)或(Ia)的化合物:包含此类化合物的组合物;此类化合物在疗法中...

Full description

Saved in:
Bibliographic Details
Main Authors CHILDS, MITCHELL, LEWIS, SAMBROOK SMITH, COLIN, PETER, HODGSON SIMON TEANBY, MAZZACCAGNI ALESSANDRO, EVANS DAVID MICHAEL, WRIGGLESWORTH JOSEPH WILLIAM, SMITH AARON JOHN, EDWARDS HANNAH JOY, DAVIE REBECCA LOUISE, YANG XUEZHENG, HINCHLIFFE PAUL STUART, CLARK, DAVID, EDWARD, BAKER THOMAS MATTHEW
Format Patent
LanguageChinese
English
Published 29.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides compounds of Formula (I) or (Ia): compositions comprising such compounds; the use of such compounds in therapy; and methods of treating patients using such compounds; wherein A, B, n, R2, R3, R4, R5 and R6 are as defined herein. 本发明提供式(I)或(Ia)的化合物:包含此类化合物的组合物;此类化合物在疗法中的用途;以及使用此类化合物治疗患者的方法;其中A、B、n、R2、R3、R4、R5和R6如本文所定义。
Bibliography:Application Number: CN201980099443